Dr. Brion Vincent Randolph, MD

Dr. Randolph practices at Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care.

Dr. Randolph's NPI, 1316148547, was assigned on May 28, 2007. Dr. Randolph graduated from University of South Carolina School of Medicine in 2003. Dr. Randolph holds Tennessee license 44535.

Dr. Randolph's primary practice is Baptist Memorial Hospital-Tipton, at 1995 Highway 51 S, Covington, TN 38019 in Tipton County. The practice phone is (901) 476-2621.

Dr. Randolph's primary practice is Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care. Dr. Randolph is also affiliated with The University of Tennessee Medical Center. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Randolph to 3 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Randolph practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Randolph's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Randolph's licenses on file in 2 states: Tennessee and South Carolina.

CMS data shows 241 Medicare services from Dr. Randolph across 4 procedure codes in 2024, for 61 Medicare patients. Medicare paid $20,591 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Randolph in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Randolph's median patient age at 68, with 57% women.

In 2024, Dr. Randolph wrote 87 Medicare Part D claims. 64% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $61,279 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Randolph for performance year 2024, reported as part of a group. Dr. Randolph accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Randolph in 2018. 2018 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation and Immunotherapy, Adoptive. Dr. Randolph's most frequent co-authors are Rohtesh S. Mehta, MD, MPH, Gheath Al-Atrash, DO, PhD and Qaiser Bashir, MD.

Dmand AI links Dr. Randolph to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Anemia, Aplastic, Leukemia, Megakaryoblastic, Acute and Bone Marrow Failure Disorders.

CMS Open Payments shows 491 general payments to Dr. Randolph from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Celgene Corporation paid the most, $279,075.

Dr. Randolph graduated from University of South Carolina School of Medicine in 2003.